Apangu, TitusGriffith, KevinAbaru, JanetCandini, GordianApio, HarrietOkoth, FelixOkello, RobertKaggwa, JohnAcayo, SarahEzama, GeoffreyYockey, BrookSexton, ChristopherSchriefer, MartinMbidde, Edward KatongoleMead, Paul2022-01-242022-01-242017Apangu, T., Griffith, K., Abaru, J., Candini, G., Apio, H., Okoth, F., ... & Mead, P. (2017). Successful treatment of human plague with oral ciprofloxacin. Emerging infectious diseases, 23(3), 553.http://dx.doi.org/10.3201/eid2303.161212https://nru.uncst.go.ug/xmlui/handle/123456789/1497The US Food and Drug Administration recently approved ciprofloxacin for treatment of plague (Yersina pestis infection) based on animal studies. Published evidence of efficacy in humans is sparse. We report 5 cases of culture-confirmed human plague treated successfully with oral ciprofloxacin, including 1 case of pneumonic plague.enplague, Yersinia pestis, human, treatment, ciprofloxacin, vector-borne infections, infectious diseases, bacterial infection, FDA approval, bacteria, zoonosesArticle